Xalacom
(OKKZZTWDFXEJAH-ATZRSLBGSA-N)
Structure
- SMILES
- O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C.O[C@@H](CCc1ccccc1)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C/CCCC(=O)OC(C)C)O
- Molecular Formula:
- C39H64N4O8S
- Molecular Weight:
- 749.012
- Log P:
- 5.1448
- Hydrogen Bond Acceptor:
- 13
- Hydrogen Bond Donor:
- 5
- TPSA:
- 194.97
- CAS Number(s):
- 852336-82-4
Synonym(s)
1.
Xalacom
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Cataract | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | Eye inflammation | FAERS: 1 | US FAERS | |
| 3 | Eye pain | FAERS: 1 | US FAERS | |
| 4 | Visual Impairment | FAERS: 1 | US FAERS | |
| 5 | Application site pain | Canada Vigilance: 1 | Canada Vigilance | |
| 6 | Dementia | Canada Vigilance: 1 | Canada Vigilance | |
| 7 | Drug ineffective | Canada Vigilance: 4 | Canada Vigilance | |
| 8 | Dry skin | Canada Vigilance: 1 | Canada Vigilance | |
| 9 | Eye irritation | Canada Vigilance: 3 | Canada Vigilance | |
| 10 | Foreign body sensation in eyes | Canada Vigilance: 1 | Canada Vigilance | |
| 11 | Headache | Canada Vigilance: 1 | Canada Vigilance | |
| 12 | Incorrect dose administered | Canada Vigilance: 1 | Canada Vigilance | |
| 13 | Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | Product quality issue | Canada Vigilance: 1 | Canada Vigilance | |
| 15 | Product substitution issue | Canada Vigilance: 3 | Canada Vigilance | |
| 16 | Pruritus | Canada Vigilance: 1 | Canada Vigilance | |
| 17 | Therapy change | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.